These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 2819091
1. Urokinase binds to a plasminogen activator inhibitor type-2-like molecule in placental microvillous membranes. Jensen PH, Nykjaer A, Andreasen PA, Lund LR, Astedt B, Lecander I, Gliemann J. Biochim Biophys Acta; 1989 Nov 17; 986(1):135-40. PubMed ID: 2819091 [Abstract] [Full Text] [Related]
2. Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers. Ramakrishnan V, Sinicropi DV, Dere R, Darbonne WC, Bechtol KB, Baker JB. J Biol Chem; 1990 Feb 15; 265(5):2755-62. PubMed ID: 2105933 [Abstract] [Full Text] [Related]
3. An inhibitor of plasminogen activation from human placenta. Purification and characterization. Wun TC, Reich E. J Biol Chem; 1987 Mar 15; 262(8):3646-53. PubMed ID: 3102492 [Abstract] [Full Text] [Related]
4. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta. Hu ZY, Liu YX, Liu K, Byrne S, Ny T, Feng Q, Ockleford CD. J Anat; 1999 Feb 15; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950 [Abstract] [Full Text] [Related]
5. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor. Chapman HA, Stone OL. Biochem J; 1985 Aug 15; 230(1):109-16. PubMed ID: 2932100 [Abstract] [Full Text] [Related]
6. Inhibitors of urokinase and thrombin in cultured neural cells. Wagner SL, Lau AL, Nguyen A, Mimuro J, Loskutoff DJ, Isackson PJ, Cunningham DD. J Neurochem; 1991 Jan 15; 56(1):234-42. PubMed ID: 1987320 [Abstract] [Full Text] [Related]
8. On the reversible interaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator and with urokinase-type plasminogen activator. Lijnen HR, Van Hoef B, Collen D. J Biol Chem; 1991 Mar 05; 266(7):4041-4. PubMed ID: 1900284 [Abstract] [Full Text] [Related]
17. A quantitative receptor assay using Triton X-114 for plasminogen activator binding proteins in solubilized membranes from human liver and placenta. Nguyen G, Kruithof EK. Anal Biochem; 1993 Feb 01; 208(2):277-82. PubMed ID: 8383929 [Abstract] [Full Text] [Related]
18. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation. Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, Li Z, Ockleford CD. Placenta; 2000 Feb 01; 21(2-3):184-93. PubMed ID: 10736241 [Abstract] [Full Text] [Related]
19. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture. Holmberg L, Lecander I, Persson B, Astedt B. Biochim Biophys Acta; 1978 Nov 15; 544(1):128-37. PubMed ID: 152655 [Abstract] [Full Text] [Related]
20. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis. Ohba K, Miyata Y, Kanda S, Koga S, Hayashi T, Kanetake H. J Urol; 2005 Aug 15; 174(2):461-5. PubMed ID: 16006865 [Abstract] [Full Text] [Related] Page: [Next] [New Search]